Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare’s Subsidiary Completes Implementation of Precision Dosing Software for One of the Nation’s Leading Healthcare Systems
Over a period of only a month, by working closely with the client pharmacy services team, the roll out of DoseMe’s proprietary precision dosing software DoseMeRx spanned eleven acute care hospitals and an outpatient infusion center. DoseMe trained hundreds of the client’s staff members representing support of the new client’s commitment to innovation in the field of medication safety.
“We are so pleased the traction DoseMe is garnering in
DoseMe’s focus is on providing solutions for individualizing the dose of medications to help healthcare professionals easily optimize therapy for each patient, resulting in improvements to mortality, risk and patient outcomes. DoseMe’s technology now supports dose optimization for tens of thousands of patients, for more than 1,000 clinicians and across more than 120 locations world-wide.
“Our mission is to continue helping patient-centered providers throughout
DoseMe’s precision dosing capabilities combine with TRHC’s proprietary Medication Risk Mitigation (MRM) technologies to enhance and accelerate medication safety solutions and will be made available to the hospital healthcare system market in the U. S. and internationally.
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
DoseMe is a
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the
T: (215) 870-0829
Bob East or Asher Dewhurst
T: (443) 213-0500
Source: Tabula Rasa HealthCare, Inc.